Table 3.
Institute | Number of cases | BraTS 2019 Overlap | DSC | HD95 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
ET | TC | WT | Avg | ET | TC | WT | Avg | |||
1 | 511 | 129 | 0.710 | 0.891 | 0.739 | 0.780 | 4.68 | 14.95 | 7.88 | 9.17 |
2 | 6 | – | 0.638 | 0.913 | 0.646 | 0.732 | 8.01 | 10.69 | 14.14 | 10.95 |
18 | 382 | – | 0.687 | 0.854 | 0.718 | 0.753 | 6.20 | 16.77 | 9.04 | 10.67 |
20 | 33 | – | 0.759 | 0.946 | 0.784 | 0.830 | 4.69 | 7.15 | 7.43 | 6.42 |
21 | 35 | – | 0.804 | 0.931 | 0.800 | 0.845 | 6.46 | 9.12 | 8.68 | 8.09 |
22 | 7 | – | 0.778 | 0.897 | 0.823 | 0.833 | 5.29 | 13.66 | 7.30 | 8.75 |
DSC and HD95 are reported for enhancing tumor (ET), tumor core (TC), and whole tumor (WT), along with their average (Avg) values for each institute.